Moexipril
Back to searchMolecule Structure
Scientific Name
Moexipril
Description of the Drug
Moexipril is an angiotensin converting enzyme inhibitor prodrug used to treat hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00691
http://www.drugbank.ca/drugs/DB00691
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Teva Pharmaceuticals Usa Inc, Glenmark Generics Ltd, Ucb Inc, Chartwell Rx Sciences Llc, Glenmark Pharmaceuticals Ltd, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Angiotensin-converting enzyme | SINGLE PROTEIN | INHIBITOR | CHEMBL1808 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34030 | |||
PharmGKB | PA164769059 | |||
Human Metabolome Database | HMDB0014829 | |||
DrugBank | DB00691 | |||
PubChem: Thomson Pharma | 14933223 | 14884255 | ||
PubChem | 91270 | 40466988 | ||
LINCS | LSM-2751 | |||
Nikkaji | J557.758F | |||
BindingDB | 50084673 | |||
EPA CompTox Dashboard | DTXSID9023330 | |||
DrugCentral | 1827 | |||
ChemicalBook | CB9338696 | |||
Guide to Pharmacology | 6571 | |||
rxnorm | MOEXIPRIL | UNIRETIC | MOEXIPRIL HYDROCHLORIDE | UNIVASC |
KEGG Ligand | C07704 | |||
ChEBI | 6960 | |||
ZINC | ZINC000003812306 |